BD to acquire Edwards Lifesciences’ Critical Care product group for $4.2bn
In a major strategic move, Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has entered into a definitive agreement to acquire the Critical Care product group from Edwards Lifesciences (NYSE: EW) for $4.2 billion in cash. This acquisition is poised to significantly bolster BD’s offerings in smart connected care solutions, leveraging Critical Care’s […]